These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2748555)

  • 61. [Histochemical study of lipid metabolism of the lungs in experimental tuberculosis and its treatment].
    Bagirova IB
    Probl Tuberk; 1978 Sep; (9):78-81. PubMed ID: 568264
    [No Abstract]   [Full Text] [Related]  

  • 62. [Treatment of patients with hyperchronic tuberculosis of the lungs].
    Svitneva AS
    Probl Tuberk; 1973; 51(1):16-20. PubMed ID: 4727152
    [No Abstract]   [Full Text] [Related]  

  • 63. Chalk and cheese: symptomatic hypocalcaemia during paediatric anti-tuberculous therapy.
    Burgner D; Schölvinck E; Coren M; Walters S
    J Infect; 2004 Aug; 49(2):169-71. PubMed ID: 15236926
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Modern aspects of the combined treatment of pulmonary tuberculosis in adolescents].
    Firsova VA; Rusakova LI; Gubkina MF; Ryzhova AP; Panova LV; Kobulashvili MG; Poluéktova FG; Iatskova TV
    Probl Tuberk; 2001; (7):21-3. PubMed ID: 11763555
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A rational approach to antioxidant therapy and vitamin E.
    Hyman M; Pizzorno J; Weil A
    Altern Ther Health Med; 2005; 11(1):14-7. PubMed ID: 15712759
    [No Abstract]   [Full Text] [Related]  

  • 66. [Efficacy of alpha-tocopherol in the complex treatment of newly diagnosed patients with destructive tuberculosis of the lungs].
    Panasiuk AV; Suslov EI; Penenko OR; Davyda RS
    Vrach Delo; 1986 Apr; (4):63-6. PubMed ID: 3716344
    [No Abstract]   [Full Text] [Related]  

  • 67. [Feasibility of pathogenetic treatment of pulmonary tuberculosis patients with and without complicating diseases].
    Keleberda KIa; Khudiakova RV; Svistunova AS; Ashirov AA
    Probl Tuberk; 1983 Apr; (4):20-5. PubMed ID: 6866963
    [No Abstract]   [Full Text] [Related]  

  • 68. [Development of agranulocytosis in long-term treatment of tuberculosis with Ethoxyd in combination with other antitubercular agents].
    Gol'dberg AS; Medved' RI
    Klin Med (Mosk); 1970 Dec; 48(12):43-7. PubMed ID: 5518596
    [No Abstract]   [Full Text] [Related]  

  • 69. [The effect of combined (corticosteroid and antibacterial) therapy on nonspecific immunologic reactivity indices in tuberculous children during the 1st years of life].
    Mikheeva GA; Rachinskiĭ SV
    Vopr Okhr Materin Det; 1967 Apr; 12(4):40-5. PubMed ID: 5298912
    [No Abstract]   [Full Text] [Related]  

  • 70. [Ambulatory therapy concepts for a "forgotten disease:" tuberculosis].
    Dtsch Med Wochenschr; 1998 May; 123(21):A32. PubMed ID: 9638100
    [No Abstract]   [Full Text] [Related]  

  • 71. [Use of lidase in the treatment of patients with fibro-cavernous pulmonary tuberculosis].
    Grigaliunas AP
    Probl Tuberk; 1974; (11):26-30. PubMed ID: 4449837
    [No Abstract]   [Full Text] [Related]  

  • 72. A paradoxical reaction during antituberculosis therapy for congenital tuberculosis.
    Park JA; Park SS; Park SE
    Int J Infect Dis; 2009 Sep; 13(5):e279-81. PubMed ID: 19124260
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Efficacy of glucocorticoids in the combined treatment of destructive pulmonary tuberculosis].
    Iareshko AG
    Probl Tuberk; 1983 Feb; (2):44-7. PubMed ID: 6844331
    [No Abstract]   [Full Text] [Related]  

  • 74. [Exacerbation of pulmonary tuberculosis during chemotherapy].
    Karachunskii MA
    Probl Tuberk; 1996; (5):23-5. PubMed ID: 8984483
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Results of use of surfactant in complex therapy of patients with destructive pulmonary tuberculosis].
    Lovacheva OV; Erokhin VV; Chernichenko NV; Evgushchenko GV; Lepekha LN; Rozenberg OA
    Probl Tuberk Bolezn Legk; 2006; (10):12-7. PubMed ID: 17139825
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Ionol as a drug for the prevention of cardiotoxic effect of antitubercular agents].
    Iakovleva TA; Dolgikh VT
    Probl Tuberk; 1984 Jan; (1):53-8. PubMed ID: 6701172
    [No Abstract]   [Full Text] [Related]  

  • 77. [Methods of pathogenetic influence in combined therapy of pulmonary tuberculosis patients].
    Makovskaia GM; Ivanova LA; Pavlova MV; Ginzburg ZI
    Probl Tuberk; 1987; (4):31-4. PubMed ID: 3601925
    [No Abstract]   [Full Text] [Related]  

  • 78. Treatment of pulmonary tuberculosis.
    LeMasters CZ
    Lippincotts Prim Care Pract; 1999; 3(1):55-8. PubMed ID: 10214202
    [No Abstract]   [Full Text] [Related]  

  • 79. Diagnostic and therapeutic challenges.
    Cohen D; Rambeloarisoa J; Florea L; Leye YM; Deplus S; Gaudric A; Farge-Bancel D; Wu L; Davis J
    Retina; 2009 Jan; 29(1):117-20. PubMed ID: 18784626
    [No Abstract]   [Full Text] [Related]  

  • 80. [Effectiveness of corticosteroid therapy of tuberculosis of the upper respiratory tract in patients with pulmonary tuberculosis].
    Varchakhova ZI
    Probl Tuberk; 1974; (11):58-61. PubMed ID: 4449847
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.